Cargando…
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
BACKGROUND AND PURPOSE: Oxidative stress [i.e. increased levels of reactive oxygen species (ROS)] has been suggested as a pathomechanism of different diseases, although the disease-relevant sources of ROS remain to be identified. One of these sources may be NADPH oxidases. However, due to increasing...
Autores principales: | Wind, S, Beuerlein, K, Eucker, T, Müller, H, Scheurer, P, Armitage, ME, Ho, H, Schmidt, HHHW, Wingler, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970907/ https://www.ncbi.nlm.nih.gov/pubmed/20860666 http://dx.doi.org/10.1111/j.1476-5381.2010.00920.x |
Ejemplares similares
-
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
por: Altenhöfer, Sebastian, et al.
Publicado: (2012) -
The 1027(th) target candidate in stroke: Will NADPH oxidase hold up?
por: Radermacher, Kim A, et al.
Publicado: (2012) -
Apocynin: Chemical and Biophysical Properties of a NADPH Oxidase Inhibitor
por: Petrônio, Maicon S., et al.
Publicado: (2013) -
Current status of NADPH oxidase research in cardiovascular
pharmacology
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2013) -
NOX1, 2, 4, 5: counting out oxidative stress
por: Wingler, K, et al.
Publicado: (2011)